{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:27:15Z","timestamp":1780108035340,"version":"3.54.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T00:00:00Z","timestamp":1561248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011421","name":"Sanofi China Investment Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ymgmr.2019.100490","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T05:35:46Z","timestamp":1561700146000},"page":"100490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Amal El","family":"Beshlawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagishwari","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod Kumar","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgmr.2019.100490_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","article-title":"A reappraisal of Gaucher disease-diagnosis and disease management algorithms","volume":"86","author":"Mistry","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgmr.2019.100490_bb0010","first-page":"S6","article-title":"Understanding the natural history of Gaucher disease","volume":"90","author":"Mistry","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.ymgmr.2019.100490_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"issue":"4","key":"10.1016\/j.ymgmr.2019.100490_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features","volume":"93","author":"Lachmann","year":"2000","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100490_bb0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-2005-871201","article-title":"Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature","volume":"25","author":"Xu","year":"2005","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2019.100490_bb0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10545-011-9313-9","article-title":"Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy","volume":"34","author":"Lo","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ymgmr.2019.100490_bb0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-125-11-199612010-00005","article-title":"Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome","volume":"125","author":"Dawson","year":"1996","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ymgmr.2019.100490_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000203562","article-title":"Pulmonary hypertension in two patients with type I Gaucher disease while on alglucerase therapy","volume":"98","author":"Harats","year":"1997","journal-title":"Acta Haematol."},{"issue":"5","key":"10.1016\/j.ymgmr.2019.100490_bb0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1183\/09031936.94.07050839","article-title":"Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach","volume":"7","author":"Rodriguez-Roisin","year":"1994","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.ymgmr.2019.100490_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057507","article-title":"Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage","volume":"8","author":"Bohte","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2019.100490_bb0055","first-page":"177","article-title":"The pathology of Gaucher disease","volume":"95","author":"Lee","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"issue":"1","key":"10.1016\/j.ymgmr.2019.100490_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00043426-199021000-00014","article-title":"Pulmonary hypertension and Gaucher's disease: logical association or mere coincidence?","volume":"12","author":"Theise","year":"1990","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.ymgmr.2019.100490_bb0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/01.CIR.35.4.783","article-title":"Gaucher's disease of the lung causing severe pulmonary hypertension with associated acute recurrent pericarditis","volume":"35","author":"Roberts","year":"1967","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100490_bb0070","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0002-9343(78)90832-X","article-title":"Unusual cardiac, renal and pulmonary involvement in Gaucher's disease. Intersitial glucocerebroside accumulation, pulmonary hypertension and fatal bone marrow embolization","volume":"65","author":"Smith","year":"1978","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgmr.2019.100490_bb0075","series-title":"The Frequency and Type of Lung Involvement in Patients with Gauchers-Disease. Laboratory Investigation","first-page":"21201","year":"1988"},{"issue":"2","key":"10.1016\/j.ymgmr.2019.100490_bb0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1183\/09031936.96.09020340","article-title":"Pulmonary function abnormalities in type I Gaucher disease","volume":"9","author":"Kerem","year":"1996","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.ymgmr.2019.100490_bb0085","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s10620-015-3593-0","article-title":"Hepatopulmonary syndrome","volume":"60","author":"Lv","year":"2015","journal-title":"Dig. Dis. Sci."},{"issue":"3 Pt 1","key":"10.1016\/j.ymgmr.2019.100490_bb0090","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm.157.3.9706057","article-title":"Pulmonary manifestations of Gaucher disease: an increased risk for L444P homozygotes?","volume":"157","author":"Santamaria","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2019.100490_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy","volume":"77","author":"Mistry","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgmr.2019.100490_bb0100","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.201008-1303OC","article-title":"A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion","volume":"183","author":"Thenappan","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"45","key":"10.1016\/j.ymgmr.2019.100490_bb0105","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ymgmr.2019.100490_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.ymgmr.2019.100490_bb0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJM199701303360516","article-title":"Gaucher cells in pulmonary-capillary blood in association with pulmonary hypertension","volume":"336","author":"Ross","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"9041","key":"10.1016\/j.ymgmr.2019.100490_bb0120","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(96)04451-0","article-title":"Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease","volume":"348","author":"Mistry","year":"1996","journal-title":"Lancet (London, England)."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426919300758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426919300758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:07Z","timestamp":1762001467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426919300758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":24,"alternative-id":["S2214426919300758"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2019.100490","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2019.100490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100490"}}